Poliovirus Vaccine, Inactivated: all 26 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Phase IV Clinical Study of sIPV Administration in Adolescent and Adult PopulationsRecruitingNCT07354269Phase 4
- Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)Not yet recruitingNCT06748612Phase 4
- A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese InfantsCompletedNCT06331156Phase 3Results posted
- Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)CompletedNCT04481191Phase 3Results posted
- Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood VaccinesCompletedNCT03530124Phase 4Results posted
- A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPVCompletedNCT03239496Phase 3Results posted
- Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) VaccineCompletedNCT01449812Phase 3Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ VaccineCompletedNCT01021293Phase 3Results posted
- Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in InfantsCompletedNCT00937404Phase 1Results posted
- Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same VaccinesCompletedNCT00547248Phase 3Results posted
- Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)CompletedNCT07297186Phase 3
- Booster Dose of sIPV Co-administered With MMR and HepA-I.CompletedNCT06442449Phase 4
- Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different ManufacturersCompletedNCT06346834Phase 4
- Safety and Immunogenicity of a Sabin Inactivated Poliovirus VaccineCompletedNCT04264598Phase 1
- Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib)CompletedNCT04264546Phase 1/2
- Immunogenicity of Intramuscular and Intradermal IPVTerminatedNCT04063150Phase 4
- Immunogenicity and Safety of Sabin-IPV Replacement VaccinationCompletedNCT04051736Phase 4
- Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in BangladeshStatus unknownNCT03890497Phase 4
- A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization ScheduleCompletedNCT03566940Phase 2
- Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPVCompletedNCT03310073Phase 4
- Comparison of Immunity Following IPV Versus fIPV: a Community Based Randomized Controlled Trial in PakistanStatus unknownNCT03286803Phase 4
- A First in Human Study to Assess the Safety, Tolerability and Immunogenicity of a Single Dose of a Trivalent Inactivated Poliovirus Vaccine Based on Sabin Strains (sIPV) Given Intramuscularly in Healthy AdultsCompletedNCT03032588Phase 1
- A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio VaccineWithdrawnNCT03016949Phase 3
- Polio End-game Strategies - Poliovirus Type 2 Challenge StudyCompletedNCT02189811Phase 4
- Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV VaccineCompletedNCT01831050Phase 4
- Inactivated Influenza Vaccine Effectiveness in Tropical AfricaCompletedNCT00893906Phase 4